49 results on '"Wouters, M."'
Search Results
2. A-190 - Imaging in Locally Advanced and Metastatic Basal Cell Carcinoma: Findings and Recommendations
3. 36MO Location and size of metastasectomy in melanoma patients treated with tumor-infiltrating lymphocytes (TIL) in relation to clinical outcome
4. 1104P Efficacy of immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD1 treatment: A EUMelareg real-world evidence study
5. 1092P Adjuvant treatment with anti-PD-1 in acral melanoma patients: A nationwide study
6. Vortices and novel superfluids in dilute atomic gases
7. 797P Relapse-free survival (RFS) update and first translational analyses of DONIMI, a study testing personalized neoadjuvant domatinostat, nivolumab (NIVO) and ipilimumab (IPI) in stage III melanoma patients (pts) based on the interferon-gamma signature (IFN-γ sign) algorithm
8. Variational path integral approach to the ground state energy of artificial atoms
9. 23P A comprehensive analysis of the mucosal melanoma immune microenvironment
10. P045 - Evaluating confocal laser microscopy to assess intraoperative surgical margin status of prostatectomy specimen, a feasibility study (ENCLOSURE-1)
11. 37P First-line BRAF/MEK-inhibitors versus anti-PD-1 monotherapy in BRAFV600-mutant advanced melanoma patients: A propensity-matched survival analysis
12. 172 Poster - Defining a “dedicated” breast cancer team
13. 1103P Long-term survival of real-world advanced melanoma patients treated with targeted therapy
14. 1120P Post-approval trials versus patient registries: Comparability of advanced melanoma patients with brain metastases
15. 1112P Intralesional therapy with talimogene laherparepvec for stage IIIB-IVM1a melanoma is able to achieve a high rate of complete and durable responses and is associated with tumour load
16. 1085P Health-related quality of life in stage III melanoma patients treated with neoadjuvant ipilimumab and nivolumab followed by index lymph node excision only versus therapeutic lymph node dissection: 24-week results of the PRADO trial
17. 1353P - Real-world outcomes of ipilimumab plus nivolumab for advanced melanoma in the Netherlands
18. 1340P - Effective treatment with T-VEC monotherapy in stage IIIB/C-IVM1a melanoma of the head & neck region
19. 1341P - Re-introduction of T-VEC monotherapy in recurrent stage IIIB/C-IVM1a melanoma is effective
20. 1297P - Pilot study: Localizing target lymph node using a magnetic marker allows reliable and representative judgement of pathological responses after neo-adjuvant ipilimumab (IPI) + nivolumab (NIVO) in macroscopic stage III melanoma
21. 1253P - High response rate with T-VEC in early metastatic melanoma (stage IIIB/C-IVM1a)
22. PO-401 Tumour stem cell characteristics are negatively associated with anti-cancer immunity in diverse solid cancers
23. PCN110 - Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice
24. 1205 - PET/CT surveillance detects asymptomatic recurrences in stage IIIB and IIIC melanoma patients: a prospective cohort study
25. 1204 - Clinical prognostic markers in stage IIIB melanoma
26. 1203 - Isolated limb perfusion for melanoma is safe and effective in elderly patients
27. 480A - Identifying best performing hospitals in colorectal cancer care; is it possible?
28. PCN214 - Quality of Life in Advanced Melanoma: Results of The Dutch Melanoma Treatment Registry
29. PCN207 - Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma: Results of the Dutch Melanoma Treatment Registry
30. PCN186 - Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands
31. PCN8 - Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands
32. PCN5 - Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands
33. PRM148 - External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma
34. 1139P - Survival in BRAF-mutant metastatic melanoma in the real-world setting: results from the Dutch Melanoma Treatment Registry
35. 1121P - Real-world survival results of metastatic melanoma patients treated with ipilimumab in the Netherlands
36. 3022 Defining a standard set of patient-centered outcomes for patients with lung cancer
37. 1207 The additional costs of obese patients after colorectal cancer surgery in the Netherlands: A retrospective multicenter study
38. 71P - Outcome After Sbrt for Potentially Operable Nsclc Patients
39. PCN37 - Impact of Hospital Volume on Breast Cancer Outcome: A Population Based Study in the Netherlands
40. FitFor2: Effects of an exercise training program on the incidence of gestational diabetes
41. PP167. A process evaluation of an innovative implementation strategy of the Dutch guidelines on hypertensive disorders in pregnancy using a computerized decision support system
42. PP095. Guideline-based development of quality indicators for hypertensive diseases in pregnancy
43. 6108 POSTER Adjuvant Chemotherapy for Colon Cancer in the Netherlands: Who Are We Treating Actually?
44. 6001 ORAL Surgical Care in Low Rectal Cancer Patients Can Be Improved – an Analysis of 4084 Patients From the Dutch Surgical Colorectal Audit (DSCA)
45. Therapeutical Options of Caesarean Scar Pregnancy: Experience of a University Hospital
46. PCN344 - The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making
47. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study
48. Resolution of the major poliovirus capsid polypeptides into doublets
49. Management of chemical warfare injuries
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.